Drugs / CSL412
last change Aug 2007 re-read 2 minutes ago

CSL412

Vaccine

Developed for
influenza
Investigated by
Seqirus

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00479648 May → Aug 2007 influenza Seqirus Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CSL412 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00479648
Modality Vaccine “adjuvanted influenza vaccineNCT00479648